While the FDA has claimed that red 3, like other additives the agency has approved ... D-N.J., joined a growing list of lawmakers urging the FDA to ban the food dye. “There is simply no ...

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval of a treatment for adults with metastatic biliary tract cancer—a condition with less than a 5 percent five-year ...

At the front of the ingredients list ... of pet foods. Instead, pet food companies are responsible for ensuring their products adhere to the AAFCO standards. The US Food and Drug Administration ...

candy and more — in food and drugs “multiple times” since it was first approved in 1969, but the petition has requested for the additive to be reviewed once more. The FDA will decide on the ...

The holidays are here, along with vibrant festive treats. But the artificial food dye giving so many sweets and drinks their ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

Anavex faces regulatory scrutiny with Alzheimer's drug submission. Despite trial setbacks, cognitive improvements shown. Read ...

Charlotte, N.C.— A pet food company based in North Carolina is recalling puppy mix sold in seven states after a batch tested positive for salmonella, the U.S. Food and Drug Administration said.

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL). The US ...

The Food and Drug Administration Modernization Act of 1997 required FDA to compile the list. It will review all comments received before development of the proposed rule in the near future.

Please click here to try out our new video viewing page (you can switch back at any time). Food and Drug Administration Commissioner Dr. Robert Califf recently testified on the agency’s proposal ...

UniQure stock doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease ...